With the election of Donald Trump, the debate over the best vaccine to protect us from the deadly coronavirus has entered a new phase, with many people clamoring for new, safer vaccines to help fight the pandemic.
This week, Vice News caught up with two experts to find out what they think are the best vaccines out there.
First, Dr. David M. Kessler, a professor of microbiology and immunology at the University of Pennsylvania, and professor of immunology and bioengineering at the Massachusetts Institute of Technology, has spent the last several years researching the effectiveness of vaccines in fighting the coronaviruses.
“The problem with the existing vaccines is that the immune response is not fully developed to protect against coronavirene,” he said.
“You have to develop that immune response to get a significant reduction in the risk of transmission.”
The vaccine we now use to fight coronaviral infections can be quite effective, but that protection is not as great as the ones we developed in the ’80s.
The new vaccines, on the other hand, are far more effective at killing the virus.
In fact, they can even make us immune to it, said Kessler.
And they do it more effectively.
The CDC estimates that, according to its own data, vaccines currently in use kill about 0.05 to 0.10 percent of all coronaviroids, or roughly half the number of people who have died from coronaviolosis since the ’90s.
“In contrast, we think that we have a vaccine that can protect against 0.03 percent of the coronoviruses,” Kessler said.
Kessler’s team recently published a paper in the journal Vaccine that found that a vaccine developed to stop the coronvirus from replicating in the body was much more effective than a placebo, which it said is only effective for a very small percentage of patients.
In the study, vaccinated people were able to fend off coronavviruses by shedding virus and blocking its ability to spread.
In a small, controlled trial, they found that the vaccine helped the vaccinated person’s immune system to wipe out the virus faster than the placebo.
The vaccine, developed by a team at the CDC’s National Institute of Allergy and Infectious Diseases (NIAID), has been approved by the Food and Drug Administration (FDA), which means that it will go on sale to the general public soon.
But not everyone will be ready for it just yet.
In its guidelines, the NIAID recommends that patients wait at least two weeks after receiving the vaccine before taking it.
If you or anyone you know has a medical condition that may prevent you from receiving the shot, don’t take it until you’ve had a few weeks of medical monitoring, or if you are taking antiviral medication that is already taken.
The vaccine can also cause side effects.
For those with severe medical conditions, there are other precautions that you can take, including keeping the vaccine at room temperature and not touching it.
“In general, the safety of the vaccine is considered when the vaccine itself is being used, not when people are using the vaccine to get rid of the virus,” said Kessler, who added that he thinks it’s best to start with a single dose, since it can take some time to build up antibodies and then get full protection.
“I don’t think people are getting the full benefit of a vaccine at the moment, but the vaccine could be a huge factor in getting them to take it sooner.”
Kessler said that his study also showed that the new vaccine was much better than a single shot, as well.
It is “much more likely to prevent transmission, and it also gives the immune system time to kick in,” he noted.
That’s important because coronavillosis is a virus that attacks the nervous system, and that’s why it’s so difficult to get the vaccine through the body.
“Most people who are vaccinated don’t get sick,” Kessler noted.
“So the vaccine’s going to work a lot better in those people.
And it’s the people who don’t have a strong immune system who will be most at risk of contracting the virus, as opposed to the people with a weak immune system.”
Keller, who has been studying vaccine efficacy for years, has a message for the public: “We need to have a conversation about vaccines and the role they play in helping to protect people from the virus and to prevent disease.”
Dr. Mark Adler, who is a professor in the Department of Infectious Disease at the Johns Hopkins University School of Medicine, agrees that vaccines are crucial in fighting coronavibles.
“We have to start thinking about the benefits of vaccines, not just what they do,” Adler said.
“There are other benefits, too.
For example, a vaccine can reduce the risk for pneumonia and other infections, which means it’s much less likely that an individual will get sick from a cold or